Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Recurrent Pregnancy Loss & the Male Contribution

Sperm DNA Fragmentation, Oxidative Stress, and the Underexamined Paternal Side of Miscarriage

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Diagnostic/clinical concept (no FDA product); the male workup in RPL is increasingly discussed by ESHRE/ASRM but not yet standardized

Reference only. Not medical advice.

What can go wrong

Acting on this is fraught: sperm DNA fragmentation assays vary in method and thresholds, no single cutoff reliably predicts outcomes, and interventions (antioxidants, lifestyle change, varicocele repair, testicular versus ejaculated sperm for ICSI) have inconsistent or weak outcome evidence. Over-testing risks unnecessary cost and anxiety; under-testing perpetuates the blind spot. Recommendations differ across professional bodies.

This is something to take to a clinician. The Atlas can tell you what is known about recurrent pregnancy loss & the male contribution in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Recurrent pregnancy loss (commonly two or more losses) is overwhelmingly worked up on the female side, yet the paternal contribution - chiefly sperm DNA fragmentation and oxidative damage - is associated with higher miscarriage risk in meta-analyses. The evidence is suggestive rather than definitive: associations are reproducible but causal proof and proven interventions are limited. The under-evaluation of the male partner in RPL is itself a notable gap in care.

Recurrent miscarriage is treated as a woman's problem - but the sperm brought half the genome.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Considering sperm DNA fragmentation testing in unexplained recurrent loss
  • Identifying modifiable paternal factors (smoking, obesity, varicocele, advanced age)
  • Counseling couples that miscarriage is not solely a female factor

How it is supposed to work

A spermatozoon delivers the paternal genome and contributes to early embryonic development. High levels of sperm DNA fragmentation - double- and single-strand breaks driven largely by oxidative stress, often abnormal protamine packaging or apoptosis - may be tolerated for fertilization but can impair embryo development after the embryonic genome activates, plausibly raising miscarriage risk. Advanced paternal age, smoking, obesity, infection, and varicocele all raise oxidative load on sperm.

What people get wrong

  • Often saidRecurrent miscarriage is a female problem

    ActuallyHalf the embryonic genome is paternal. Meta-analyses link elevated sperm DNA fragmentation to higher miscarriage risk, yet the male is frequently not evaluated.

  • Often saidA high DNA-fragmentation result means antioxidants will fix the miscarriages

    ActuallyNot proven. Antioxidant and other interventions show inconsistent outcome benefit, and assay thresholds are not standardized; results should guide, not dictate, action.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

What we do not know

  • Does treating high sperm DNA fragmentation (lifestyle, varicocele repair, testicular sperm) actually reduce live-birth-loss in RPL?
  • Which DNA-fragmentation assay and threshold, if any, are clinically actionable?
  • Should male evaluation be standard in every recurrent-loss workup?

At a glance

RPL definition
Commonly 2+ (or 3+) consecutive pregnancy losses
Male link
Elevated sperm DNA fragmentation associated with higher loss risk
Typical workup
Heavily female-focused; male often not evaluated
Evidence grade
Associative; causal proof and proven therapy limited

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Recurrent Pregnancy Loss & the Male Contribution. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Meta-analyses of sperm DNA fragmentation and pregnancy loss2010s (e.g., Robinson et al. 2012; Zhao et al. 2014; McQueen et al. 2019)

    Higher sperm DNA fragmentation was consistently associated with increased miscarriage risk across pooled cohorts, including in couples with recurrent loss

  • Advanced paternal age and miscarriageMultiple cohorts

    Older paternal age has been associated with modestly higher miscarriage risk, consistent with accumulating sperm DNA damage and de novo mutation

  • ESHRE recurrent pregnancy loss guideline2017/2018, updated

    Acknowledged the male/lifestyle contribution and sperm DNA fragmentation as relevant, while noting evidence and treatment gaps